[HTML][HTML] Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
…, S Schreiber, E Théâtre, AE Van Der Meulen-De… - The Lancet, 2016 - thelancet.com
Background Crohn's disease and ulcerative colitis are the two major forms of inflammatory
bowel disease; treatment strategies have historically been determined by this binary …
bowel disease; treatment strategies have historically been determined by this binary …
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
…, PC van de Meeberg, AE van der Meulen-de… - Gut, 2014 - gut.bmj.com
Objective The introduction of anti tumour necrosis factor-α (anti-TNFα) therapy might impact
healthcare expenditures, but there are limited data regarding the costs of inflammatory …
healthcare expenditures, but there are limited data regarding the costs of inflammatory …
Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease
…, HW Verspaget, WE Fibbe, AE van der Meulen-de… - Gastroenterology, 2015 - Elsevier
Background & Aims Patients with perianal fistulizing Crohn’s disease have a poor prognosis
because these lesions do not heal well. We evaluated the effects of local administration of …
because these lesions do not heal well. We evaluated the effects of local administration of …
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility
…, S Targan, D Turner, HH Uhlig, AE van der Meulen… - Nature …, 2022 - nature.com
Genome-wide association studies (GWASs) have identified hundreds of loci associated with
Crohn’s disease (CD). However, as with all complex diseases, robust identification of the …
Crohn’s disease (CD). However, as with all complex diseases, robust identification of the …
Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial
MJ de Jong, AE van der Meulen-de… - The Lancet, 2017 - thelancet.com
Background Tight and personalised control of inflammatory bowel disease in a traditional
setting is challenging because of the disease complexity, high pressure on outpatient clinics, …
setting is challenging because of the disease complexity, high pressure on outpatient clinics, …
One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome
…, WHV tot Nederveen, AE van der Meulen–de… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are
associated with Lynch syndrome. Dominant clustering of CRC (non-Lynch syndrome) accounts …
associated with Lynch syndrome. Dominant clustering of CRC (non-Lynch syndrome) accounts …
[PDF][PDF] Mass cytometry of the human mucosal immune system identifies tissue-and disease-associated immune subsets
…, M Temurhan, T Höllt, AE van der Meulen-de… - Immunity, 2016 - cell.com
Inflammatory intestinal diseases are characterized by abnormal immune responses and affect
distinct locations of the gastrointestinal tract. Although the role of several immune subsets …
distinct locations of the gastrointestinal tract. Although the role of several immune subsets …
MicroRNA214 is associated with progression of ulcerative colitis, and inhibition reduces development of colitis and colitis-associated cancer in mice
…, M Koutsioumpa, G Koukos, AE Van Der Meulen-De… - Gastroenterology, 2015 - Elsevier
Background & Aims Persistent activation of the inflammatory response contributes to the
development of inflammatory bowel diseases, which increase the risk of colorectal cancer. We …
development of inflammatory bowel diseases, which increase the risk of colorectal cancer. We …
Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease
…, CY Ponsioen, B Oldenburg, AE van der Meulen–de… - Gastroenterology, 2014 - Elsevier
… Ponsioen 2 , Bas Oldenburg 3 , Andrea E. van der Meulen–de Jong 4 , Gerard Dijkstra 5 ,
Marina JAL Grubben 6 , Cornelis JHM van Laarhoven 7 , Iris D. Nagtegaal 8 , Frank Hoentjen …
Marina JAL Grubben 6 , Cornelis JHM van Laarhoven 7 , Iris D. Nagtegaal 8 , Frank Hoentjen …
High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease
…, N Mahmmod, AE van der Meulen-de… - Clinical …, 2018 - Elsevier
Background & Aims Patients with inflammatory bowel disease (IBD) and primary sclerosing
cholangitis (PSC, termed PSC-IBD) are at increased risk for colorectal cancer, but their risk …
cholangitis (PSC, termed PSC-IBD) are at increased risk for colorectal cancer, but their risk …